Medicine and Dentistry
Activated Protein C
17%
Activated Protein C Resistance
66%
Acute Leukemia
36%
Acute Myeloid Leukemia
31%
Antithrombotic
23%
APC
15%
Assay
82%
Betrixaban
31%
Biological Marker
100%
Blood Stasis
31%
Bone Turnover
31%
Cells
36%
Circulating microRNA
36%
Clinical Study
31%
Coagulation
15%
Contraceptive Agent
39%
COVID-19
31%
Diffuse Large B-Cell Lymphoma
31%
Disseminated Intravascular Coagulation
31%
Donor
44%
Drug Resistance
26%
Estetrol
31%
Factor V Leiden
16%
Hemostat
41%
Heparin
23%
Histone
23%
HL60
31%
Inpatient
52%
Leukemia Cell
31%
Lipid
18%
Malignant Neoplasm
35%
Metabolism
31%
microRNA
51%
Multidrug Resistance
31%
Nucleosome
31%
Observational Study
31%
Oral Contraceptive
31%
Patient
99%
Placebo
31%
Plasma
78%
Postmenopause
31%
Procoagulant
39%
Septic Shock
31%
Spontaneous Remission
23%
Therapeutic Procedure
32%
Thrombin
70%
Thromboplastin
22%
Thrombosis
39%
Vascular Endothelium
31%
Woman
31%
Pharmacology, Toxicology and Pharmaceutical Science
Activated Protein C
12%
Activated Protein C Resistance
63%
Acute Leukemia
42%
Acute Myeloid Leukemia
31%
Amine
10%
Anticoagulant Agent
12%
Betrixaban
31%
Biological Marker
10%
Blood Clotting Factor 10a Inhibitor
15%
Blood Clotting Factor 5 Leiden
12%
Buffer
10%
Cell Death
10%
Circulating microRNA
10%
Clinical Study
31%
Clotting Time
37%
Cytomegalovirus
21%
Direct Oral Anticoagulant
9%
Disseminated Intravascular Clotting
31%
DNA (Cytosine 5) Methyltransferase 1
10%
DNA Methyltransferase
10%
DNA Methyltransferase 3A
31%
Eculizumab
31%
Edoxaban
31%
Estrogen Receptor
15%
Fibrinolytic Agent
9%
Fondaparinux
10%
Heparin
15%
Histone H3
10%
Histone Methyltransferase
31%
Low Molecular Weight Heparin
10%
Luciferase
10%
Lymphoma
10%
Lysine
10%
Malignant Neoplasm
21%
Methyltransferase
10%
microRNA
31%
microRNA 20a
10%
Multidrug Resistance Protein 1
31%
Multiple Drug Resistance
31%
Nucleic Acid
10%
Paroxysmal Nocturnal Hemoglobinuria
31%
Phospholipid
10%
Procoagulant
31%
Promyelocytic Leukemia
10%
Prothrombin
27%
Quinazoline
10%
Relapse
10%
Thrombin
45%
Thromboplastin
13%
Venous Thromboembolism
15%
Nursing and Health Professions
Analyzer
23%
Anticoagulant Agent
25%
APC
31%
Blood Clotting Time
13%
Bone Turnover
31%
Carbohydrate
13%
Control
7%
Eculizumab
31%
Edoxaban
31%
Estetrol
31%
Experiment
7%
Fibrinolytic Agent
9%
Flow Cytometry
7%
Laboratory
7%
Lipid
18%
Low Molecular Weight Heparin
7%
Parameters
16%
Paroxysmal Nocturnal Hemoglobinuria
31%
Pathophysiology
31%
Patient
15%
Placebo
31%
Procoagulant
11%
Reproducibility
9%
Sample
31%
Sex Hormone Binding Globulin
9%
Standardization
39%
Steroid
6%
Temperature
7%
Thrombin
63%
Thrombocyte Free Plasma
11%
Time
7%
Woman
31%